Point72 Hong Kong Ltd - SEATTLE GENETICS INC ownership

SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 390 filers reported holding SEATTLE GENETICS INC in Q1 2020. The put-call ratio across all filers is 0.47 and the average weighting 0.3%.

Quarter-by-quarter ownership
Point72 Hong Kong Ltd ownership history of SEATTLE GENETICS INC
ValueSharesWeighting
Q1 2020$88,000
-49.1%
763
-49.5%
0.04%
-4.9%
Q4 2019$173,000
-64.5%
1,512
-73.5%
0.04%
-70.9%
Q3 2019$488,000
+154.2%
5,716
+106.5%
0.14%
+166.0%
Q2 2019$192,0002,768
+92166.7%
0.05%
Q3 2018$0
-100.0%
3
-99.8%
0.00%
-100.0%
Q1 2018$82,000
+8100.0%
1,558
+10286.7%
0.04%
+4100.0%
Q1 2017$1,000
-90.9%
15
-92.5%
0.00%
-83.3%
Q3 2016$11,0002000.01%
Other shareholders
SEATTLE GENETICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
Baker Brothers Advisors 50,060,240$5,775,950,00035.57%
Lagoda Investment Management, L.P. 72,969$8,419,0009.97%
Avidity Partners Management LP 580,000$66,920,0009.25%
Arabesque Asset Management Ltd 14,807$1,708,0003.53%
Boxer Capital, LLC 400,000$46,152,0003.15%
Woodline Partners LP 364,333$42,037,0003.00%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 56,900$6,557,0002.99%
SECTORAL ASSET MANAGEMENT INC 107,000$12,346,0002.37%
Capital International, Inc./CA/ 1,197,659$138,186,0002.33%
Bain Capital Public Equity Management II, LLC 169,641$19,573,0002.29%
View complete list of SEATTLE GENETICS INC shareholders